The goal of the career development program at M.D. Anderson Cancer Center SPORE in prostate is to develop a cadre of investigators dedicated to translational studies in human prostate cancer. The program will 1) recruit, train physicians and post-doctoral fellows to ask and answer questions that will enable them to become competent translational investigators in the field of prostate cancer. 2) To provide training in basic science principles of cancer biology that is not commonly included in clinical fellowship training or Ph.D. programs. 3) To provide specific knowledge of research in prostate cancer that will enhance the ability of the awardees to conduct innovative translational science directed toward this disease. The unique educational environment that exists at MDACC will assure that the goals will be met. Three career development awardees will be selected annually. Solicitations will be made for qualified candidates from within and outside of the institution. Given the large pool of qualified candidates within the MDACC, it is likely that most fellowship trainees will be selected from this group of investigators. Awardees will be selected from the pool of candidates who have responded to the solicitation based on objective criteria laboratory investigators that will provide comprehensive training of awardees. The mentors have been selected from a larger and diverse group of scientists and clinicians because of their interests in translational science and skill as educators and mentors. The program will be evaluated annually and modifications in the selection process of training made when appropriate.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA090270-02
Application #
6563957
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-01-24
Project End
2002-12-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
$291,807
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Salameh, Ahmad; Lee, Alessandro K; Cardó-Vila, Marina et al. (2015) PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3. Proc Natl Acad Sci U S A 112:8403-8
Pasqualini, Renata; Millikan, Randall E; Christianson, Dawn R et al. (2015) Targeting the interleukin-11 receptor ? in metastatic prostate cancer: A first-in-man study. Cancer 121:2411-21
Euscher, Elizabeth; Fox, Patricia; Bassett, Roland et al. (2013) The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol 37:1728-36
Efstathiou, Eleni; Karlou, Maria; Wen, Sijin et al. (2013) Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. Prostate 73:153-61
Hosain, G M Monawar; Sanderson, Maureen; Du, Xianglin L et al. (2012) Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population. Am J Mens Health 6:249-57
Heymach, John V; Shackleford, Terry J; Tran, Hai T et al. (2011) Effect of low-fat diets on plasma levels of NF-?B-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prev Res (Phila) 4:1590-8
Hosain, G M Monawar; Sanderson, Maureen; Du, Xianglin L et al. (2011) Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. Cent Eur J Public Health 19:30-4
Kadowaki, Yoshihiko; Chari, Nikhil S; Teo, Albert E K et al. (2011) PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells. Apoptosis 16:627-35
Efstathiou, Eleni; Abrahams, Neil A; Tibbs, Rita F et al. (2010) Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification. Eur Urol 57:1030-8
Ravoori, Murali; Czaplinska, Aneta J; Sikes, Charles et al. (2010) Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One 5:e9854

Showing the most recent 10 out of 153 publications